Kimberly-Clark Corporation (KMB) is a leading consumer products organization with a brand portfolio that includes household names like Kleenex and Huggies. The company’s products are sold in more than 175 countries with a No. 1 or No. 2 share position in approximately 80 countries around the world.
The company generated 49% of its revenue from Personal Care, 36% of its revenue from Consumer Tissue, 15% of revenue from K-C Professional and the remainder from other sources during the fourth quarter of 2020.
Tissue Segment Drives Q4 Growth
Kimberly-Clark reported fourth-quarter revenue that rose by 5.7% to $4.84 billion, beating consensus estimates by $110 million, with non-GAAP earnings of $1.69 per share, beating consensus estimates by seven cents. Not surprisingly, Consumer Tissue drove better-than-expected growth with a 14% year-over-year increase in revenue.
Management expects to see a 4 to 6% improvement in sales during FY2021, which is higher than the 2.84% improvement that analysts expected. Adjusted earnings growth is also projected to be higher than analysts were expecting at $7.75 to $8.00 per share.
The company raised its quarterly dividend by 6.5% to $1.14 per share, which represents a 3.5% forward yield. The dividend is payable on April 5, 2021 to shareholders on record as of March 5, 2021.
The company also authorized a new $5 billion share repurchase program that supplements that current $5 billion authorization expected to be completed later this year.
Want to keep track of all dividend increases? Subscribe to Dividend.com and have complete access to our exclusive dividend increases list here.